Indication
Rabies
14 clinical trials
28 products
Product
VerorabProduct
Imovax RabiesClinical trial
Immunogenicity and Safety of a Purified Vero Rabies Vaccine - Serum Free in Comparison With Verorab® and Imovax® Rabies, in a Pre-exposure Regimen in Both Pediatric and Adult Populations and a Single Booster Dose of Purified Vero Rabies Vaccine - Serum Free Administered at 1 Year Post-3-dose Primary Series, and Between 2 up to 3 Years Post-One Week 2-Dose Primary Series in a Subset of Adults in ThailandStatus: Active (not recruiting), Estimated PCD: 2020-03-25
Clinical trial
A Phase III, Randomized, Comparator-Controlled, Double-Blind, Multicenter Study to Evaluate the Immunogenicity, Safety and Lot to Lot Consistency of Three Lots of a PIKA Rabies Vaccine（Vero Cell）for Human Use,Freeze-dried in Healthy Adults Using a Post-Exposure Prophylaxis ScheduleStatus: Active (not recruiting), Estimated PCD: 2024-03-22
Product
Purified vero rabies vaccineProduct
ChirorabProduct
PIKA Rabies VaccineClinical trial
A Randomized, Blinded, Parallel Controlled Phase 3 Clinical Trial to Evaluate the Immunogenicity and Safety of Freeze-dried Human Rabies Vaccine (Without Serum Vero Cells) Administered to People Aged 10-60 Years With Different Immunization ProceduresStatus: Not yet recruiting, Estimated PCD: 2024-04-01
Product
Control vaccineProduct
4-dose AProduct
5-dose group of test vaccineClinical trial
Immunity Persistence After Abridged Intradermal Rabies PEPStatus: Completed, Estimated PCD: 2023-02-01
Clinical trial
A Phase III Randomized Blinded Study to Evaluate SYN023 Compared to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies in Adults With Category III Rabies Exposure RisksStatus: Completed, Estimated PCD: 2022-06-24
Clinical trial
A Phase 2b Randomized Blinded Study to Evaluate SYN023 Compared to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies in Adults With Different Rabies Exposure RisksStatus: Completed, Estimated PCD: 2021-12-23
Product
Rabies vaccineProduct
SYN023Product
HRIGProduct
Rabies VaccineProduct
Human Rabies Immune GlobulinClinical trial
Immunogenicity and Safety of a Purified Vero Rabies Vaccine-Serum Free (VRVg) Assessed With the Institut Pasteur du Cambodge (IPC: 2-2-2-0-0) and the Thai Red Cross (TRC: 2-2-2-0-2) Intradermal Regimens as Simulated Rabies Post-exposure Prophylaxis in Healthy Subjects in ThailandStatus: Completed, Estimated PCD: 2022-03-19
Product
Human rabies immunoglobulinsProduct
Purified Vero Rabies VaccineClinical trial
Immunogenicity and Safety of the Purified Vero Rabies Vaccine - Serum Free (VRVg) Using the Zagreb Regimen as Simulated Rabies Post-exposure Prophylaxis in Healthy Adults in ThailandStatus: Completed, Estimated PCD: 2021-06-23
Clinical trial
A Randomized, Single-arm, Phase Ⅰ Clinical Trial to Evaluate the Safety of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried Vaccinated With Different Immunization Schedule in People Aged 10-60 YearsStatus: Active (not recruiting), Estimated PCD: 2024-06-30
Clinical trial
A Phase 1, Dosage-Escalation Study of the Safety and Immunogenicity of a Novel Rabies Vaccine ChAd155-RG vs. the Comparator RABAVERT Vaccine in Healthy Adult SubjectsStatus: Completed, Estimated PCD: 2023-03-24
Product
ChAd155-RGClinical trial
An Open-label, Randomized Study Evaluating the Safety and Immunogenicity of the Purified Vero Cell Rabies Vaccine PVRV Administered Intradermally and Intramuscularly as Post-exposure ProphylaxisStatus: Completed, Estimated PCD: 2021-08-30
Product
PVRVClinical trial
A Phase Ib/II Age De-escalation, Dose Escalation, Partially Randomised, Open-label Head-to-head Study of the Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabGStatus: Active (not recruiting), Estimated PCD: 2028-09-01
Product
ChAdOx2 RabGProduct
Inactivated Rabies VaccineClinical trial
Multicenter Safety Evaluation of Human Rabies Immune Globulin 300 IU/mL in ChildrenStatus: Recruiting, Estimated PCD: 2024-06-01
Product
Human rabies immune globulinClinical trial
A Cross-over, Open-label, Randomized Study Evaluating the Safety and Immunogenicity of the Inactivated Rabies Vaccine RABIVAX-S on Healthy Vietnamese Volunteers With 3 Doses of Pre-exposure ProphylaxisStatus: Completed, Estimated PCD: 2020-07-02
Product
RABIVAX-S